Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats. 1996

S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
Department of Medicine, University of Southern California School of Medicine, Los Angeles, CA 90033, USA.

Eisai hyperbilirubinemic rats (EHBR) are mutant Sprague-Dawley rats that exhibit impaired biliary organic anion and reduced glutathione (GSH) secretion. In addition, liver GSH levels are twice that of age-matched controls. The mechanisms for the defect in biliary GSH secretion and the increase in cell GSH are not fully understood. We previously showed that canalicular membrane-enriched vesicles isolated from EHBR livers exhibited normal GSH transport. In the present study, we examined the steady-state rat canalicular reduced glutathione transporter (RcGshT) messenger RNA (mRNA) and protein levels, as well as the mechanisms for the increase in cell GSH. Both Northern and Western blot analyses of EHBR livers showed nearly identical RcGshT mRNA and polypeptide levels, respectively, as compared with controls. Treatment with phenobarbital, which increased steady-state RcGshT mRNA by five- to sixfold, RcGshT polypeptide, and biliary GSH secretion by onefold in controls, had a smaller effect on steady-state RcGshT-mRNA level in EHBR (by 1.5-fold) and did not increase RcGshT polypeptide or biliary GSH secretion. In examining possible mechanisms for increased liver GSH, both cysteine level and gamma-glutamylcysteine synthetase (GCS) activity were significantly higher than controls, while the activity of GSH synthetase was unchanged. Northern and Western blot analyses also showed increased steady-state GCS heavy subunit (GCS-HS) mRNA and polypeptide levels, respectively. In addition to liver, GSH levels in kidney, duodenal, jejunal, and ileal mucosa of EHBR were 200% to 300% of age-matched control rats. GCS activity was also increased in kidney cytosol of EHBR. Thus, the defect in biliary GSH secretion in EHBR most likely is either at the posttranslational level of RcGshT or in the inhibition exerted by retained endogenous organic anions. In addition, there is a widespread up-regulation of GSH synthesis capacity in the tissues of EHBR.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body

Related Publications

S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
January 1992, The Journal of biological chemistry,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
January 1994, Drug metabolism and disposition: the biological fate of chemicals,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
June 1993, The Journal of pharmacology and experimental therapeutics,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
January 1996, Biological trace element research,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
February 1998, The Journal of pharmacology and experimental therapeutics,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
March 1999, Pancreas,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
January 1995, Antimicrobial agents and chemotherapy,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
October 1996, Biopharmaceutics & drug disposition,
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
October 1994, Hepatology (Baltimore, Md.),
S C Lu, and J Cai, and J Kuhlenkamp, and W M Sun, and H Takikawa, and O Takenaka, and T Horie, and J Yi, and N Kaplowitz
August 1995, Digestive diseases and sciences,
Copied contents to your clipboard!